Neurodevelopmental outcome of Italian preterm ELBW infants: an eleven years single center cohort

All consecutive infants born with birth weight < 1000 g and admitted within 6 h from birth to the neonatal intensive care unit (NICU) of the “Fondazione IRCCS Policlinico San Matteo” hospital in Pavia, Italy, from Jan 1, 2005, to Dec 31, 2015 were eligible for inclusion (Fig. 1). All patients with congenital malformations and/or genetic disorders were excluded. The study was approved by the Ethical Committee Area Vasta Pavia—Fondazione IRCCS Policlinico San Matteo.

We recorded obstetric, perinatal and neonatal data for every newborn enrolled according to the Vermont Oxford Network (VON) database collection criteria [14]. The clinical risk index for babies (CRIB) score was calculated as previously described [15]. The time needed to recover from postnatal weight loss was recorded as the number of days required to restore birth weight.

Per institutional protocol, serial cerebral ultrasound (cUS), was performed in all preterm infants. All infants born before 35 weeks GA underwent cerebral cUS evaluation within the first 24 h of life. In infants born before 30 weeks GA, cUS was performed at 24, 48 and 72 h of life, at 7 days of life, then weekly up to 31 weeks post-menstrual age (PMA) and then at 36 and 40 weeks PMA. In infants born between 30 and 33 weeks GA, a first evaluation was performed within the first week of life, a second one at 3 weeks, and then at 40 weeks PMA [16]. Intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL) and ventricular dilatation (VD) were classified according to Papile et al., de Vries et al., and to Ment et al. [17‐19], respectively.

Following the Rademaker classification, cUS scans performed at 40 weeks of postmenstrual age (PMA) were classified as “normal”, “slightly abnormal” in the presence of grade I/II IVH, grade I PVL, germinal layer necrosis, or a combination of these features, or isolated VD; “severely abnormal” cUS scans was defined in the presence of grade III/IV IVH, cystic grade II/III PVL, thalamic lesions, focal infarction, or post-hemorrhagic VD needing surgical intervention [20].

A child neuropsychiatrist, unaware of the cUS findings, examined each subject at 38–42 weeks of PMA. The neurological evaluation of the infant was based on the methods of Amiel-Tison: this assessment is divided into six sections and includes 34 items covering cranial assessment, neurosensory function and spontaneous motor activity, passive muscle tone, axial motor activity (active tone), primitive reflexes, palate and tongue, adaptedness to manipulations during assessment, feeding autonomy [21]. Neonatal neurological assessments in preterm infants at term age were classified as “normal” or “abnormal” in the absence or presence of any pathological neurological sign, respectively [21].

Each child underwent neurodevelopmental assessment every three months during the first year and every six months in the second year [22]. The Griffiths’ Mental Developmental Scales – Extended Revised (GMDS -ER) [23] were used to obtain child General Quotient (GQ) and the five sub-quotients scores (locomotor, personal-social, hearing and speech, eye-hand coordination, performance) at 24 months of CA. In addition, ophthalmological and audiometric examinations were performed periodically to exclude specific sensory abnormalities [22]. At 24 months of corrected age (CA), infants were classified into three categories according to their neurodevelopmental outcome: “normal” if they had a normal neurological assessment and a GQ ≥ 88; “minor sequelae” if they showed tone and reflex abnormalities or asymmetry without functional deficits, or at least one sign from the triad described by Amiel-Tison and Gosselin [24], GQ between 76 and 87, squint and refractive errors, mild hypoacusia; and “major sequelae” if they presented disabling or non-disabling Cerebral Palsy (CP), a GQ ≤ 75, sensorineural hearing loss requiring active intervention, or severe central or peripheral visual impairment [22].

The continuous variables were reported as mean and standard deviation if normally distributed, as median and interquartile range (IQR: 25th–75th percentile) if not normally distributed. The categorical variables were expressed as counts and percentages.

Comparison between two groups for continuous variables were performed using Student’s t test if normally distributed or the analogous non parametrical test of Mann Whitney if not normally distributed; continuous variables were compared between three groups with the ANOVA test or with the analogous non parametrical Kruskall-Wallis test. Association between categorical variables were studied with the Pearson’s χ² or with the Fisher’s exact test.

Correlation between the scores reported in the GMDS-ER subscales were tested by calculating the Spearman correlation coefficient rho.

Each variable of potential clinical interest was tested in a univariate multinomial (polytomous) regression model in order to assess a potential statistical significance in the association with the outcome sequelae.

The risk factors of clinical (neurological, paediatric, obstetric) interest for which a statistical significance in the association with sequelae at the univariate analysis and for which no collinearity was reported were included as regressors in a multivariate multinomial logistic model.

During the study period, two hundred and ninety ELBWi were admitted to the NICU of “Fondazione IRCCS Policlinico San Matteo” hospital. Mean GA at birth was 26.2 (sd 2.4, range 22–33) weeks, and mean birth weight was 750.8 (sd 154.6) g.

Twenty-two infants had a birth weight ≤ 500 g. There were 262 inborn infants (90.3%) while outborn were 28 (9.7%). Two infants were excluded from the analysis due to genetic disorders. Eighty infants (27.6%) died during NICU stay. All infants with birth weight ≤ 500 g died in NICU. GA and BW were significantly lower among infants who died compared with survivors (mean GA at birth 25.1 weeks [sd 2.6 weeks] versus 26.6 weeks [sd 2.2 weeks], p-value < 0.001;BW 668 g [sd 164.5 g] versus 782.68 g [sd 138.29 g], p-value < 0.001 respectively). None of the surviving infants died after NICU discharge home. Two hundred and eight surviving children met the inclusion criteria and were enrolled. One hundred seventy-six children (84.6%) completed the follow-up evaluation and constituted the study group. No differences in perinatal medical data, cUS findings, or neurological assessment at 40 weeks of PMA were found between the study group and the subjects lost to follow-up.

Table 1 shows the sociodemographic, obstetric and neonatal variables divided by neurodevelopmental outcome. cUS findings and neurological assessment at term age, are reported in Table 1 and Table 2.

One hundred eighteen (67.05%) infants showed a neurodevelopmental outcome within the normal range at 24 months of CA. Fifty-eight patients (32.95%) had an “non-optimal” outcome: 30 cases (17.04%) showed minor sequelae and 28 cases (15.91%) major sequelae. In the “major sequelae” group, eight infants (4.54% of the whole sample) had CP, 4 of them with a non-disabling form and could walk unassisted. Severe developmental delay without other associated deficits was observed in 15 infants (8.52% of the sample). Sensory deficits were present in 7 children (2 with visual impairment and 5 with sensorineural hearing loss requiring active intervention). More details are shown in Table 3.

GMDS-ER scores are available for 174/176 patients. The median GQ was 100 (25th: 88, 75th:106). The median scores obtained on the subscales are shown in Fig. 2. The median score on the Hearing-Speech subscale was significantly lower than the median scores recorded on all the other subscales. Analyzing the pairwise correlation between all the GMDS-ER subscales, the hearing Speech subscale always shows a weaker correlation (rho = 0.48; p < 0.001), as reported in Additional Table 1. This weaker correlation together with the statistical significance persisted and was found to be more marked after restricting the analysis to the children with normal GQ (rho = p < 0.001), as reported in Additional Table 2.

Children who reported a GQ score > 75 had significantly higher gestational age (26.71 [sd 0.18] weeks) than children who reported a GQ score ≤ 75 (25.22 [sd 0.37] weeks; p value for the comparison = 0.002). Results of comparison of GQ Scale and related subscales between the two groups with different gestational age (< 26 weeks of GA; ≥ 26 weeks of GA) were reported in Additional Table 3, confirming that children < 26 weeks of GA reporting lower mean scores than the children ≥ 26 weeks of GA.

Otherwise, birth weight was significantly associated with GQ score, with children who reported GQ score > 75 showing a mean birth weight equal to 791.01 (sd = 10.4) grams versus a mean birth weight of 687.22 8sd 0 40.82) among children with a GQ score ≤ 75.

Table 4 reports results of both univariate and multivariate analysis of risk factors associated with neurodevelopmental sequelae.

Severely abnormal cUS findings and bronchopulmonary dysplasia (BPD) were the most important predictors of major sequelae (respectively RRR = 20.73 – p value = 0.006 for severely abnormal cUS findings; RRR = 6.26 – p value = 0.001 for BPD).

Abnormal neurological examination at 40 weeks PMA (scoring based on the methods of Amiel-Tison and Gosselin [21, 24], including pathological signs of variable degree, in particular no fix and track, abnormal spontaneous activity, excessive neck extensor muscles response) degree and red blood cell transfusion were found to be statistically significant risk factors for major sequelae, with a weaker association than the ones aforementioned (respectively RRR = 5.49 – p value < 0.001; 4.63 – p value = 0.045). Pathological neurological examination at term age has been identified as a moderate risk factor for minor sequel too.

Further weak association, even if with statistical significance of the association with major sequelae, was reported for CRIB, time needed for birthweight recovery and total parenteral nutrition (respectively RRR = 1.19 – p value = 0.002; RRR = 1.12 – p value = 0.010; RRR = 1.06; p value = 0.011). In contrast, female gender resulted as a moderate protective factor for major sequelae (RRR = 0.41- p value = 0.040), as well as a greater gestational age (RRR = 0.66; p-value = 0.001) Post-natal steroid administration is a moderate risk factor only for minor sequelae (RRR 3.10 p = 0.008).

The multivariate model was performed by including the variables of clinical interest for which no collinearity was reported.

Multivariate multinomial logistic regression analysis confirmed severely abnormal cUS findings and BPD as independent risk factors significantly associated to major sequelae (respectively RRR = 10.22—p value = 0.043 for severely abnormal cUS findings; RRR = 4.36 – p value = 0.008 for BPD) and only BPD as predictor for minor sequelae (RRR = 2.95; p value = 0.020).

Our study is one of the few investigating the neurodevelopmental outcome at two years of corrected age of ELBWi born in the 2000s in Italy [22, 49]. Overall, 80% of enrolled participants completed the follow-up, a cut-off used to define high-quality randomized trials [50].

The single-center design of the study meant that highly homogeneous standards of care were applied to all participants throughout the study period and ensured methodological consistency of data collection during the follow-up.

In this retrospective study obstetrical data are complete and available only for a subgroup of infants. Among incomplete maternal data, there were maternal emotional well-being and stress perception, stressful life events, depressive symptoms and pregnancy-related anxiety, known to be associated with neurodevelopmental outcomes in extremely preterm infants [51].

Additionally, the predictive value of neurological examination improves with the analysis of GMs’ trajectories; however, video-recordings with the strict methodology needed for research are difficult to obtain for every patient in routine clinical settings. Nevertheless, the quality of spontaneous motility has been evaluated during the neurological examination performed at 40 weeks PMA. Unfortunately, we do not have neonatal brain MRI data available for all patients: it would be interesting to evaluate them, in particular in the proportion of children with cognitive delay at 24 months of corrected age.